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ABSTRACT
Objectives: To explore inequalities in the care
experiences of care by patients clinical or trust-level
factors for patients with cancer.
Design: Secondary analysis of data from the National
Cancer Patient Experience Survey 2011–2012.
Setting and participants: Adult patients with a
primary diagnosis of cancer who attended an acute or
specialist National Health Service (NHS) trust in England.
Outcome measure: OR of a patient rating their overall
care positively, adjusting for other patient, clinical and
trust-level factors.
Methods: Using cross-sectional data from 71 793
patients with cancer who completed the National Cancer
Patient Experience Survey 2011–2012, we examined
associations between patient, clinical and trust-level
factors and a summary measure of patient experience,
namely overall rating of care. Multivariate logistic
regression was used to investigate variation by
sociodemographic characteristics adjusting for other
patient, clinical and trust-level factors.
Results: Female, non-white and younger patients were
less likely to rate their overall care as excellent or very
good. Patients with long-standing conditions, particularly
those with learning disabilities or mental health
conditions, also reported poorer overall care. This
variation persisted when other patient, clinical and trust-
level factors were controlled for, indicating that there are
real differences in experiences among patients with
cancer by sociodemographic characteristics.
Conclusions: There is evidence of inequalities in the
experiences of patients with cancer in the UK by
sociodemographic characteristics such as gender, age,
ethnicity and disability. Quality cancer care services must
strive to meet the needs of a diverse patient population
equally; this study identifies patient groups for whom it
appears cancer care services are in greatest need of
improvement.
INTRODUCTION
Patient experience is a key component of
quality in healthcare and is one of the top
priorities in the National Health Service
(NHS).1 However, studies in the UK indicate
that there are systematic differences in
patient experience by sociodemographic
characteristics.2–4 For example, studies on
primary and hospital care have found that
patients tend to report more positive experi-
ences with increasing age,4–8 females report
less positive experiences than males5 6 and
non-white patients report less positive experi-
ences than white patients, even after
adjusting for other sociodemographic vari-
ables.3 5 6 9 Less is known about variation in
the experiences of patients with cancer.
There are currently 1.8 million people living
with cancer in the UK10 and advances in
cancer treatments mean that they are living
longer and facing prolonged periods of
contact with healthcare services because of
complex treatment regimens.11 In 2011, a
department of health (DH) report set out
the government’s strategy to improve
Strengths and limitations of this study
▪ To the best of our knowledge, this is the first
study to explore patients’ overall rating of cancer
care by sociodemographic characteristics includ-
ing long-standing conditions or disabilities.
▪ A principal strength of this study is the large
sample size (>71 000) and high response rate
(68%).
▪ As this study involves secondary analysis
of national survey data it is limited by the type of
data available, for example, the influence of
potentially important predictors of patient experi-
ence such as employment status, level of depriv-
ation and health status could not be explored as
these data were not gathered.
▪ A further limitation is that the binary categorisa-
tion of patients’ responses condenses the
patients’ experiences (which were already limited
to several multiple choice options) and may
mask potentially significant variations.
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outcomes by putting patients at the heart of cancer
health services.10 A key objective of this strategy was to
reduce inequalities in care relating to both clinical out-
comes and patient experience. Thus, exploration of the
experiences of patients with cancer and the inequalities
that may exist is critical in order to identify patient
groups for whom cancer care services are in greatest
need of improvement.
Detailed studies on the experiences of patients with
cancer have often relied on small sample sizes.12–14
However, a regular National Cancer Patient Experience
Survey (NCPES) has been established which provides a
wealth of information on care and treatment experiences.
The 2011–2012 survey includes responses from over
71 000 patients with cancer from 160 trusts across the
UK.15 With a relatively high response rate and large
sample size, the survey presents an opportunity to explore
inequalities in the quality of care received by patients with
cancer. Here, we aim to describe the variation in the
experiences of patients with cancer by age, gender, ethni-
city and presence of long-standing conditions or disabil-
ities in order to explore whether there are systematic
inequalities. We further examine the inﬂuence of clinical
and trust-level factors on these variations.
METHODS
Source of data
We carried out a secondary analysis of 2011–2012
NCPES cross-sectional data collected by Quality Health
(Chesterﬁeld, UK) on behalf of the DH. All patients
with a primary diagnosis of cancer who attended an
NHS hospital as an inpatient or day case between 1
September 2011 and 30 November 2011 were sent the
survey.15 Non-responders were followed up with two
postal reminders. The ﬁnal response rate achieved was
68%. As no survey weights were available, the data could
not be weighted to adjust for non-response. The dataset
included demographic and clinical characteristics for
71 793 patients with cancer who attended 160 hospital
trusts across England, as well as their responses to 70
multiple choice questions relating to various aspects of
their experiences of care. Surveys such as NCPES are
commonly used to measure patient experience over a
range of domains; however, single summary measures of
overall experience, such as the Family and Friends Test,
have become increasingly important.1 Our analysis
focused on a summary measure of patient experience,
namely patients’ assessment of care as measured by Q70
in the survey, “Overall, how would you rate your care?”
Responses from a ﬁve-point scale were transformed into
a binary outcome, with ‘excellent’ and ‘very good’ cate-
gorised as ‘positive’ and ‘good’, ‘fair’ and ‘poor’ as ‘not
positive’, in accordance with the DH Survey Guidance.15
Patient, clinical and trust-level characteristics
The main sociodemographic characteristics of interest in
this study (gender, age and ethnicity) were ascertained
by self-report16 and grouped as in the national report.15
As Chinese patients have reported less positive experi-
ences than white patients elsewhere,3 6 17 the ‘Chinese’
ethnic category was not combined with ‘Other’ in this
analysis. For age and ethnicity the largest groups were
chosen as the reference category. Responses to the ques-
tion “Do you have any of the following long-standing
conditions?” were used to identify patients with
comorbidities. The clinical characteristics of tumour
group and patient status (ie, day or inpatient) were
taken from hospital administration records.
Patients with haematological cancer were assigned as
the reference tumour group as the largest group
(breast) did not have a representative age and gender
distribution. Time since ﬁrst treatment was ascertained
by patients’ survey responses. As trust-level factors have
previously been associated with patient experience6 18–20
several were included in this analysis. Hospital trusts
were categorised by type (large acute, medium acute,
small acute, specialist and teaching) and by foundation
status. The Care Quality Commission’s (CQCs) 2008/
2009 Annual Health Check rating and the proportion of
front-line staff satisﬁed with care at their trust (Q12d
from the National NHS Staff Survey 2012) were also
included as measures of trusts’ overall quality. Quintiles
of staff satisfaction were used as a categorical variable
during regression analysis with the lowest quintile as ref-
erence category. The reference categories chosen for
other trust-level factors were the largest groups.
Data analysis
Variation in patents’ overall rating of care by patient,
clinical and trust-level factors was investigated using uni-
variate logistic regression. Respondents with missing
demographic, clinical or trust-level data or those who
did not answer Q70, were then excluded (ie, complete-
case analysis was undertaken) and multivariate logistic
regression was used to describe associations between the
individual demographic characteristics of interest and
overall rating of care. Confounding by patient, clinical
and trust-level factors was controlled for through their
sequential addition to the model. Logistic regression was
chosen as the small intraclass coefﬁcient calculated for
Q70 (<0.01) suggested the effect of clustering by trust
among respondents was negligible; therefore, it was
anticipated that a multilevel model and a multivariate
logistic regression model would produce similar
results.21 However, as even small intraclass correlations
can inﬂate type-1 errors, clustered robust SEs were uti-
lised. All statistical analyses were conducted in Stata V.12.
RESULTS
Patient characteristics and rating of care
A total of 71 793 patients admitted to hospital trusts
across England with a primary cancer diagnosis com-
pleted the survey. Table 1 shows the demographic and
clinical characteristics of respondents and table 2 the
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Table 1 Characteristics of survey respondents and their unadjusted associations with a positive overall rating of care from univariate logistic regression
Patient characteristics Clinical characteristics
n Per cent OR (95% CI) p Value n Per cent OR (95% CI) p Value
Gender Tumour group
Male 33 832 47.1 1 (ref) Brain/CNS 746 1.0 0.52 (0.42 to 0.63) <0.001
Female 37 961 52.9 0.92 (0.88 to 0.96) <0.001 Breast 14 739 20.5 1.00 (0.92 to 1.09) 0.98
Colorectal/lower GI 9483 13.2 0.72 (0.66 to 0.78) <0.001
Age group Gynaecological 4202 5.9 0.72 (0.64 to 0.80) <0.001
16–25 363 0.5 0.68 (0.51 to 0.92) 0.01 Haematological 11 070 15.4 1 (ref)
26–35 969 1.4 0.62 (0.52 to 0.75) <0.001 Head and neck 2422 3.4 0.71 (0.62 to 0.81) <0.001
36–50 6802 9.5 0.70 (0.64 to 0.76) <0.001 Lung 5029 7.0 0.77 (0.69 to 0.85) <0.001
51–65 22 885 31.9 0.79 (0.74 to 0.83) <0.001 Other 1138 1.6 0.72 (0.59 to 0.86) <0.001
66–75 23 643 32.9 1 (ref) Prostate 5831 8.1 0.70 (0.64 to 0.78) <0.001
76+ 17 131 23.9 0.85 (0.79 to 0.90) <0.001 Sarcoma 2451 3.4 0.61 (0.53 to 0.69) <0.001
Skin 1695 2.4 0.98 (0.82 to 1.16) 0.80
Ethnicity Upper GI 4540 6.3 0.61 (0.55 to 0.68) <0.001
White 63 652 88.7 1 (ref) Urological 8447 11.8 0.64 (0.58 to 0.70) <0.001
Mixed 199 0.3 0.66 (0.45 to 0.97) 0.04
Asian/Asian British 1082 1.5 0.33 (0.29 to 0.38) <0.001 Patient status
Black/Black British 885 1.2 0.41 (0.35 to 0.49) <0.001 Day case 45 720 63.7 1 (ref)
Chinese 138 0.2 0.27 (0.19 to 0.39) <0.001 Inpatient 26 073 36.3 0.84 (0.80 to 0.88) <0.001
Other 510 0.7 0.58 (0.46 to 0.73) <0.001
Time since first treatment
Long-standing conditions*† <1 year 44 997 62.3 1 (ref)
None 48 218 67.2 1–5 years 17 486 24.4 0.83 (0.78 to 0.87) <0.001
Deafness/hearing impairment 7281 10.1 0.91 (0.85 to 0.98) 0.01 >5 years 6212 8.7 0.88 (0.81 to 0.95) 0.002
Blindness/partially sighted 1856 2.6 0.74 (0.65 to 0.84) <0.001
Physical condition 9347 13.0 0.71 (0.67 to 0.76) <0.001
Learning disability 354 0.5 0.50 (0.39 to 0.65) <0.001
Mental health condition 1347 1.9 0.55 (0.48 to 0.64) <0.001
Long-standing illness‡ 9241 12.9 0.77 (0.73 to 0.82) <0.001
Total number of respondents=71 793. Ethnicity was unknown for 7.4% respondents, long-standing conditions status for 7.3% and time since first treatment for 4.3%. Significant associations at
α=0.05 level highlighted in italics.
*6.7% of patients (n=4780) had >1 long-standing condition, therefore the column total exceeds 100%.
†Reference category for specific long-standing conditions is not having that condition.
‡Such as (but not limited to) HIV, diabetes, chronic heart disease or epilepsy.
CNS, central nervous system; GI, gastrointestinal.
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characteristics of the hospital trusts they attended. The
majority of patients were white, female and >50 years old
and there were substantial numbers with disabilities or
other long-standing conditions. The most common
tumour groups were breast and haematological cancers.
Most respondents had started their treatment in the last
year and were admitted to hospital as day case patients
on their most recent visit. Most were treated in large
acute trusts, trusts with foundation status and trusts rated
‘Good’ by CQC. The majority of patients (96.5%,
n=69 276) provided a response to Q70 “Overall, how
would you rate your care?” In total 87.8% rated their
care as ‘excellent’ or ‘very good’ while the remaining
12.2% rated their care ‘good’, ‘fair’ or ‘poor’ (ﬁgure 1).
Variation in rating of care by patient-level, clinical-level
and trust-level factors
Unadjusted associations between patient-level, clinical-
level and trust-level characteristics and Q70 from univari-
ate logistic regression analysis are shown in tables 1
and 2. Among all respondents, statistically signiﬁcant
variation in overall rating of care by patient-level
characteristics such as ethnicity, gender, age and long-
standing conditions was observed. For example, women
were less likely than men, and non-white patients were
less likely than white patients, to rate their overall care
very good or excellent. Chinese patients reported least
favourably among non-white ethnic minorities. Younger
and older patients were less likely than 66–75-year-olds
to rate their care very good or excellent, with the young-
est patients (16–24-year-olds) least likely to report excel-
lent or very good overall care. Patients with any
long-standing condition were less positive about their
overall care; those with a learning disability or mental
health condition were the least satisﬁed.
Clinical-level and trust-level characteristics were also
associated with overall rating of care. With the exception
of patients with breast and skin cancer, all other patients
Table 2 Characteristics of trusts attended by survey respondents and their unadjusted associations with a positive overall
rating of care from univariate logistic regression
Trust-level characteristics
n Per cent OR (95% CI) p Value
Trust type
Small acute 6240 8.7 1.23 (1.12 to 1.34) <0.001
Medium acute 16 677 23.2 1.07 (1.01 to 1.14) 0.02
Large acute 25 850 36.0 1 (ref)
Specialist 3224 4.5 1.54 (1.36 to 1.76) <0.001
Teaching 19 802 27.6 1.03 (0.98 to 1.10) 0.24
Foundation status
No 31 798 44.3 0.82 (0.78 to 0.85) <0.001
Yes 39 995 55.7 1 (ref)
CQC trust quality rating (2008/9)
Weak 3926 5.6 0.85 (0.77 to 0.94) 0.001
Fair 18 482 26.2 0.97 (0.92 to 1.03) 0.34
Good 28 425 40.3 1 ref
Excellent 19 748 28.0 1.17 (1.10 to 1.24) <0.001
Frontline staff satisfied with care*
Mean 63.5% Quintiles of front-line staff satisfied with care†
Median 62.7% 1 (lowest) 1 (ref)
Range 35.3–94.0% 2 1.10 (1.03 to 1.19) 0.01
3 1.11 (1.03 to 1.19) 0.004
4 1.17 (1.09 to 1.26) <0.001
5 (highest) 1.35 (1.25 to 1.45) <0.001
Total number of respondents=71 793. CQC trust quality rating was unknown for three trusts (1.7% of respondents) and the proportion of
front-line staff satisfied with care was unknown for 1 trust (1.7% of respondents). Significant associations at α=0.05 level highlighted in italics.
*Calculated from responses to Q12d from the National NHS Staff Survey 2012.
†Trusts were categorised into quintiles according to the proportion of staff responding positively to Q12d.
CQC, Care Quality Commission.
Figure 1 Responses from NCPES 2011-12 to Q70 “Overall,
how would you rate your care”?
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were less likely than those with haematological cancers
to rate their care as very good or excellent. Inpatients,
patients who began their treatment more than 1 year
ago and those who attended large acute trusts, trusts
without foundation status or trusts with a ‘weak’ CQC
rating were also less likely to rate their care as very good
or excellent.
Variation in patients’ rating of care adjusting for clinical
and trust-level factors
After excluding those with missing demographic, clinical
or trust-level data or those who did not provide a rating
of their overall care, 60 528 respondents from 150 trusts
remained for complete-case analysis. The distribution of
patient, clinical and trust-level characteristics in the
‘complete-case’ and ‘all respondents’ populations was
similar (see online supplemetary table S1) and there was
little difference in the univariate associations between
the demographic characteristics and overall rating of
care (with the exception of being deaf/having a hearing
impairment which was not associated with a poorer
rating of overall care during complete-case analysis,
table 3). Model 1 in table 3 shows the effect of mutually
adjusting for all patient-level factors. The observed vari-
ation in rating under univariate logistic regression was
mostly unaffected; negative associations between rating
overall care positively and being female, younger, non-
white or having a long-standing condition persisted. The
magnitude of the associations was generally stable
though there was a slight increase in the effect of having
a mental health condition or learning disability and
being of mixed ethnicity was no longer signiﬁcantly asso-
ciated. The addition of clinical factors (tumour group,
time since ﬁrst treatment and in-patient or day-patient
status) to the regression model (model 2) had little
impact on variation by age or ethnicity, but the negative
association between being female and care rating
increased in magnitude. Including trust-level character-
istics in the full multivariate model (model 3) had a
minimal effect on the associations between patients’
sociodemographic characteristics and rating of care.
Even when adjusting for clinical, trust and other patient-
level factors clear variation in patients’ rating of care by
sociodemographic characteristics such as gender, age,
ethnicity and long-standing conditions was evident.
Female, younger, non-white patients or patients with a
long-standing condition remained less likely to rate their
overall care as excellent or very good.
DISCUSSION
Our analysis of the 2011–2012 NCPES demonstrates that
there is marked variation in the experiences of patients
with cancer by sociodemographic factors. Women,
younger patients, ethnic minorities and patients with a
long-standing condition or disability were less likely to
rate their cancer care as ‘excellent or “very good”. This
variation remained after adjusting for clinical factors,
such as tumour group and duration of treatment and
trust-level factors. This suggests that the variation by
sociodemographic factors is not a result of confounding
but is attributable to real differences in experiences
among these groups.
To the authors’ knowledge, this was the ﬁrst study to
explore overall rating of care by patients with cancer by
sociodemographic characteristics including long-
standing conditions or disabilities. A principal strength
of this study is the large sample size (>71 000) and the
response rate of 68%, which was signiﬁcantly higher
than that achieved by comparable surveys.22 23 Also, as
all patients with cancer treated by the NHS in England
during the assigned 3 month study period were sent the
survey, it is likely that ﬁndings can be generalised to the
wider population of patients with cancer. The main lim-
itations of this study relate to the type of data available.
The data for the trust quality score was collected
approximately 3 years prior to the NCPES survey period
and so may not reﬂect the quality of the trust at the
time of patient admission. The inﬂuence of other poten-
tially important predictors of patient experience such as
employment status,20 level of deprivation5 and health
status2 8 24 could not be explored as these data are not
gathered through the NCPES. Furthermore, the binary
categorisation of patients’ responses, as per DH Survey
Guidance, condenses the patients’ experiences (which
were already limited to several multiple choice options)
and may mask potentially signiﬁcant variations.
Interpretation of the ﬁndings from NCPES data requires
consideration of the possible determinants of variation in
patients’ responses to a survey question. First, it is possible
that variation reﬂects differing health, emotional or other
support needs that are not met by cancer care ser-
vices.12 14 25 Second, differential expectations between
patient groups, perhaps pertaining to sociocultural norms,
may contribute to the observed patterns.8 26 Third, certain
patient groups may have a tendency to respond less posi-
tively, based on shared norms regarding feedback and
ideas as to its purpose.26 Finally, variation may reﬂect real
differences in the quality of care provided.8 26
Studies of patient experience in the general patient
population have demonstrated systematic differences in
experience by gender, age and ethnicity and the results
of our study further add to this knowledge by demon-
strating that similar variation exists among patients with
cancer. Adjusting for other sociodemographic factors,
women were less likely to report positive experiences
than men. This may be due to the increased emotional
and support needs among female patients with cancer
described elsewhere.13 14 Breast cancer was the most
common tumour group for females (38.4%, n=14 591)
and in comparison to other tumour groups patients with
breast cancer were more likely to rate their care posi-
tively. Notably, when clinical factors such as tumour
group were adjusted for, the magnitude of the negative
association between gender and overall care rating
increased. This may indicate that while patient
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Table 3 Association between positive rating of overall care and demographic characteristics adjusting for patient-level, clinical-level and trust-level factors
Multivariate
Univariate* Model 1† Model 2‡ Model 3§
OR (95% CI) p Value ORadj (95% CI) p Value ORadj (95% CI) p Value ORadj (95% CI) p Value
Gender
Male 1 (ref) 1 (ref) 1 (ref) 1 (ref)
Female 0.91 (0.87 to 0.96) <0.001 0.93 (0.88 to 0.98) 0.02 0.72 (0.68 to 0.76) <0.001 0.72 (0.68 to 0.77) <0.001
Age group
16–25 0.65 (0.48 to 0.90) 0.01 0.68 (0.48 to 0.98) 0.04 0.61 (0.43 to 0.88) 0.01 0.58 (0.41 to 0.82) 0.002
26–35 0.67 (0.55 to 0.81) <0.001 0.71 (0.60 to 0.86) 0.001 0.64 (0.53 to 0.77) <0.001 0.62 (0.51 to 0.75) <0.001
36–50 0.68 (0.63 to 0.75) <0.001 0.71 (0.65 to 0.78) <0.001 0.61 (0.56 to 0.67) <0.001 0.60 (0.54 to 0.65) <0.001
51–65 0.76 (0.72 to 0.81) <0.001 0.77 (0.73 to 0.82) <0.001 0.73 (0.68 to 0.77) <0.001 0.72 (0.68 to 0.77) <0.001
66–75 1 (ref) 1 (ref) 1 (ref) 1 (ref)
76+ 0.85 (0.79 to 0.91) <0.001 0.86 (0.80 to 0.93) <0.001 0.90 (0.83 to 0.97) 0.01 0.90 (0.84 to 0.98) 0.01
Ethnicity
White 1 (ref) 1 (ref) 1 (ref) 1 (ref)
Mixed 0.65 (0.44 to 0.97) 0.04 0.70 (0.45 to 1.10) 0.12 0.68 (0.44 to 1.08) 0.10 0.67 (0.43 to 1.04) 0.08
Asian 0.35 (0.30 to 0.40) <0.001 0.37 (0.31 to 0.44) <0.001 0.35 (0.30 to 0.42) <0.001 0.35 (0.30 to 0.41) <0.001
Black 0.45 (0.37 to 0.53) <0.001 0.46 (0.38 to 0.56) <0.001 0.46 (0.37 to 0.56) <0.001 0.43 (0.36 to 0.53) <0.001
Chinese 0.26 (0.18 to 0.38) <0.001 0.28 (0.19 to 0.41) <0.001 0.29 (0.20 to 0.42) <0.001 0.27 (0.18 to 0.41) <0.001
Other 0.61 (0.47 to 0.77) <0.001 0.62 (0.48 to 0.79) <0.001 0.61 (0.47 to 0.79) <0.001 0.61 (0.47 to 0.77) <0.001
Long-standing conditions¶
Deafness/hearing impairment 0.95 (0.87 to 1.02) 0.16 0.93 (0.85 to 0.99) 0.09 0.93 (0.85 to 1.01) 0.09 0.93 (0.85 to 1.01) 0.09
Blindness/visual impairment 0.78 (0.68 to 0.90) 0.001 0.85 (0.74 to 0.97) 0.01 0.85 (0.75 to 0.98) <0.001 0.86 (0.75 to 0.99) 0.03
Physical condition 0.73 (0.68 to 0.78) <0.001 0.73 (0.69 to 0.77) <0.001 0.73 (0.69 to 0.77) <0.001 0.74 (0.70 to 0.78) <0.001
Learning disability 0.49 (0.38 to 0.65) <0.001 0.66 (0.49 to 0.88) 0.01 0.68 (0.51 to 0.90) 0.01 0.67 (0.50 to 0.90) 0.01
Mental health condition 0.58 (0.50 to 0.67) <0.001 0.65 (0.57 to 0.74) <0.001 0.65 (0.57 to 0.74) <0.001 0.65 (0.57 to 0.74) <0.001
Long-standing illness 0.79 (0.74 to 0.85) <0.001 0.79 (0.74 to 0.85) <0.001 0.80 (0.75 to 0.86) <0.001 0.81 (0.75 to 0.87) <0.001
Significant associations at α=0.05 level with clustered robust SEs highlighted in italics.
*Figures may differ from those presented in tables 1 and 2 as they are based on 60 528 respondents from 150 trusts with complete data (ie, complete-case analysis).
†Adjusted for patient factors (ie, ethnicity, gender, age group, specific long-standing conditions).
‡Adjusted for patient factors and clinical factors (ie, patient status, tumour group and time since first treatment).
§Adjusted for patient factors, clinical factors and trust-level factors (ie, trust type, foundation status, CQC trust quality rating and quintile of front-line staff satisfied with care).
¶Reference category for specific long-standing conditions is not having that condition.
Ref=reference category.
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experience varies modestly overall by gender there are
marked differences between men and women with less
common cancers. This is an area which merits further
exploration.
Younger patients were less likely to report positive
experiences than older patients, which corroborates pre-
vious ﬁndings in relation to age and patient satisfac-
tion.4–8 13 27 It has been suggested that this observation
may reﬂect a generational phenomenon, whereby older
patients’ responses are inﬂuenced by comparisons with
their parents’ generation who may not have had access
to advanced technologies of modern treatment or the
free care provided by the NHS, referred to as ‘gratitude
bias’.28 29 Alternatively, younger patients may have
higher expectations of quality of care due to a reduced
frequency of hospital visits compared to older patients.17
The poorer rating of care in the oldest age group (76+
years) ﬁts with neither theory, hence further work to
understand the cause of variation by age in the experi-
ences of patients with cancer is required.
Ethnic minorities, especially Asian and speciﬁcally
Chinese patients, reported less positive experiences than
white patients. This trend is similar to ﬁndings from pre-
vious studies exploring variation in patient experiences
of care generally2 4 5 and speciﬁcally for cancer.17 22 The
extent to which these results are due to cultural differ-
ences in expectations of care or willingness to criticise is
unclear and necessitates further research. Of signiﬁcant
concern is the possibility that these patients experience
poorer quality of care owing to a lack of understanding
of the care needs of these minority groups or to discrim-
ination, unintended or otherwise.8
Patients with various long-standing conditions reported
signiﬁcantly less positive patient experiences than those
without. The worst experiences were reported by patients
with a learning disability or mental health condition.
Given the small numbers of patients in these groups and
the strength of the association it seems likely that there is
marked variation in their experiences compared with
other patients. Patients with long-standing illnesses such as
diabetes and chronic heart disease were also less likely to
rate their care as ‘excellent’ or ‘very good.’ Given that the
number of patients with such illnesses is set to rise in the
future with an ageing patient population it is important to
explore how having comorbidities inﬂuences patients’
experience of cancer care.
This study presents evidence of inequalities in experi-
ences of cancer care by gender, age, ethnicity and dis-
ability. While it is possible that some of the variation
observed between patient groups is a result of varying
sociocultural expectations or tendencies to rate care
positively, it is also possible that the quality of care truly
differs between patient groups. Further investigation of
the experiences of women, ethnic minorities, younger
patients and those with a disability is needed so that
cancer care services can be better tailored to meet the
needs and expectations of these groups. Analysis of the
NCPES qualitative free text questions and other patient
experience data at a trust level would help to inform
quality improvement initiatives. The ﬁndings of this
study would appear to suggest that, if used as a compara-
tive performance indicator (as is NCPES data), patient
experience measures should be adjusted for age, gender
and ethnicity. For example, an unadjusted measure of
performance could unfairly disadvantage hospital trusts
with higher than average proportion of ethnic minority
patients . However, the impact of adjusting NCPES data
for demographic characteristics on trust rankings has
been shown to be minimal.30 Adjusting for gender, age
and ethnicity causes few trusts to move into or out of the
top or bottom 20% of trusts nationally. While they may
not account for much of the between-trust variation in
the experiences of patients with cancer, the overall vari-
ation in patient experience by demographic factors is
important in its own right and warrants further
attention.
Responses to survey questions are a result of patients’
perception and interpretation of events, which are
shaped by expectations and clinical or emotional needs,
in addition to the quality of services received. Meeting
the care needs of all patients equally is a fundamental
principle of the NHS and high-quality cancer services
must strive to meet the needs of its diverse patient popu-
lation. This study identiﬁes patient groups for which
cancer care services are in greatest need of
improvement.
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